A Phase 2, Open-label Study of Encorafenib + Binimetinib in Patients with BRAF V600E-mutant Non-small Cell Lung Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Array BioPharma Inc
Start Date
June 26, 2019
End Date
June 30, 2025
Administered By
Duke Cancer Institute
Awarded By
Array BioPharma Inc
Start Date
June 26, 2019
End Date
June 30, 2025